Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs (2026-03-09)
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.